How Long After Injection Does Wegovy Work — and What Should You Expect?

The biggest misconception: that each injection 'kicks in' within hours

A lot of people expect to feel different the day after their first Wegovy injection. That is completely understandable, injections feel clinical and deliberate, and the mind looks for an immediate signal. In reality, semaglutide builds up in your system gradually. After a single dose, blood levels peak roughly 24 to 72 hours later, but those levels are relatively low at the start of treatment. The medicine accumulates week on week, which is why the question of how long after injecting Wegovy it starts working does not have a single-hour answer.

By about four to five weeks in, semaglutide reaches what pharmacologists call steady-state concentration, the point where each new dose tops up a stable reservoir rather than starting from near zero. It is from around this point that the appetite-suppressing, gastric-slowing effects are working at their intended level. Waiting for an overnight result and feeling nothing is one of the more common reasons people worry unnecessarily in the first fortnight. The medicine is doing something; it is just not doing it all at once. Understanding how the Wegovy pen delivers the dose can help put the mechanics in context.

The NHS semaglutide page notes that side effects, if they occur, often appear early, which is itself evidence that the medicine is active from the first injection. The appetite-reduction, however, tends to be subtler at the starter dose.

What most people notice, and when

The honest picture, drawn from the STEP 1 trial data and real-world prescribing experience, looks roughly like this. In the first one to two weeks, some people notice a mild reduction in hunger or feel satisfied after eating less, particularly towards the end of the first week. Others notice nothing beyond any injection-site tenderness. Both are normal. Nausea is common in this window; it is not a signal the medicine is causing harm, but rather that your gastrointestinal system is adjusting to a new chemical signal.

By weeks four to eight, when the dose has usually increased at least once, appetite suppression tends to become more consistent. Many people describe eating smaller portions without consciously deciding to. Weight changes on the scale often become measurable here, though the STEP 1 trial (published in the New England Journal of Medicine and involving adults without type 2 diabetes) showed that statistically significant average weight loss accumulated over 68 weeks, reaching around 15% of body weight at the 2.4 mg maintenance dose. That figure represents a long arc, not a sprint. You can read more about how soon after injection semaglutide starts working for a closer look at the pharmacokinetics.

Weeks twelve onwards, once you are closer to or at maintenance dose, is typically where the most noticeable weight-loss progress accumulates. Plateaus can occur and are normal; they do not necessarily mean the medicine has stopped working.

Why the titration schedule shapes how long it takes to feel anything

Wegovy's licensed schedule starts at 0.25 mg weekly for four weeks, stepping up through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose. The starter dose is not a therapeutic target, its job is to let your body adjust and reduce the likelihood of severe nausea. This is one reason that people sometimes feel very little at first: they are not yet at the dose where the full appetite-modifying effect is intended to operate.

The prescriber decides the titration pace, and there are good clinical reasons not to rush it. Jumping doses does not speed up the long-term outcome and tends to increase the risk of gastrointestinal side effects. If you are wondering how the pace compares to other medicines, the overview of available weight-loss treatments sets out how different options work. For a cost context around private treatment, the Wegovy cost guide explains what's typically included in a private prescription price.

A note on microdosing: some people consider adjusting their own doses to manage side effects. This is not recommended without clinical guidance, the question of whether you can microdose a Wegovy pen is addressed separately, and the short answer is that altering your dose is a conversation for your prescriber, not a self-management decision.

When to expect weight loss versus appetite change, and when to talk to your prescriber

Appetite change and weight loss are related but not the same event. Appetite can shift within weeks; the weight loss that results from consistently eating less takes longer to register on a scale, and longer still to reach a point your GP would call clinically meaningful. If you are at maintenance dose for at least three months and have seen less than 5% weight loss, that is a marker both NICE and clinical practice take seriously, it's a signal to review whether to continue, adjust, or reconsider the approach.

Signs that do warrant prompt contact with a prescriber rather than patient waiting include: persistent severe nausea or vomiting that prevents normal eating; severe stomach pain, especially if it radiates to the back (a symptom the MHRA has specifically highlighted in relation to acute pancreatitis with GLP-1 medicines); or any allergic reaction. Report suspected side effects via the MHRA Yellow Card scheme. For broader questions about what to expect from treatment, our Wegovy guide covers the full picture, and our team at nume includes GPhC-registered prescribers who review every consultation personally. If you have questions before committing to anything, the simplest step is to speak to our prescribers, it costs nothing and there is no obligation.